JFO Open Ophthalmology最新文献

{"title":"Validation of the Spanish version of the IVI_C VRQoL in children from 8 to 18 years old","authors":"Carlos Fresno Cañada ,&nbsp;Joan Gispets Parcerisas ,&nbsp;Nazaret Fresno Cañada ,&nbsp;Héctor Salvador Hernandez ,&nbsp;Ana Llorca Cardeñosa ,&nbsp;Alejandro Martinez Roda ,&nbsp;Joan Prat Bartomeu","doi":"10.1016/j.jfop.2024.100095","DOIUrl":"https://doi.org/10.1016/j.jfop.2024.100095","url":null,"abstract":"<div><h3>Purpose</h3><p>To validate the Spanish version of the Impact of Vision Impairment for Children (IVI_C), a vision-related quality of life (VRQoL) questionnaire, using Rasch Analysis.</p></div><div><h3>Methods</h3><p>A translation and adaptation of the English IVI_C test was performed according to the standards published in PedsQL. The IVI_C Spanish version of the test was administered by email to 101 Sant Joan de Déu Hospital patients who were invited to respond twice, with a minimum interval of two months. The age of the patients ranged from 8 to 18 years. Statistical software SPSS 19.0 (Armonk, NY: IBM Corp.) was used to perform the statistical analyses to test the internal consistency of the scale, the test-retest, the intraclass correlation consistency and the Rasch Analysis.</p></div><div><h3>Results</h3><p>Results ranging from good to excellent were obtained for the internal consistency of the scale, the test-retest and the intraclass correlation, depending on the scale used, and Rasch Analysis validated to simplify the original test. The statistical analysis of the 24 original items was carried out, and the 6 items that provided almost no contribution to the overall score were removed. Thus, 18 out of the 24 items in the original test were selected.</p></div><div><h3>Conclusion</h3><p>The Spanish version of the IVI_C QoL test with 18 items is a valid tool to assess the quality of life of patients with visual loss who do not have additional disabilities.</p></div>","PeriodicalId":100740,"journal":{"name":"JFO Open Ophthalmology","volume":"6 ","pages":"Article 100095"},"PeriodicalIF":0.0,"publicationDate":"2024-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949889924000199/pdfft?md5=7cb0ea4860fb5c02a8d135504016c8d3&pid=1-s2.0-S2949889924000199-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140041592","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pearl on the Hill - A rare OCT finding","authors":"R. Kaur ,&nbsp;S. Rai ,&nbsp;B. Khan","doi":"10.1016/j.jfop.2024.100097","DOIUrl":"10.1016/j.jfop.2024.100097","url":null,"abstract":"","PeriodicalId":100740,"journal":{"name":"JFO Open Ophthalmology","volume":"5 ","pages":"Article 100097"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949889924000217/pdfft?md5=092f17b43623ff0eef0a10f331445549&pid=1-s2.0-S2949889924000217-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140087954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Idiopathic orbital inflammation as first presentation of Crohn’s disease in a pediatric patient","authors":"Grace S. Yin ,&nbsp;Daniel Mulder ,&nbsp;Christine Law","doi":"10.1016/j.jfop.2024.100098","DOIUrl":"10.1016/j.jfop.2024.100098","url":null,"abstract":"","PeriodicalId":100740,"journal":{"name":"JFO Open Ophthalmology","volume":"5 ","pages":"Article 100098"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949889924000229/pdfft?md5=f4cde4bed55e59fc211fe9e0d38de14e&pid=1-s2.0-S2949889924000229-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140091245","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Outcomes of phaco-trabeculectomy versus phaco-viscocanalostomy for primary open angle glaucoma","authors":"Mahdi Sharifzadeh Kermani,&nbsp;Maryam Abbasi Moghaddam,&nbsp;Mahla Shadravan,&nbsp;Ali Sharifi,&nbsp;Arash Daneshtalab,&nbsp;Amin Zand","doi":"10.1016/j.jfop.2024.100091","DOIUrl":"https://doi.org/10.1016/j.jfop.2024.100091","url":null,"abstract":"<div><h3>Purpose</h3><p>This study aimed to compare the intraocular pressure (IOP)-lowering effect and postoperative adverse effects of combined phacoemulsification and trabeculectomy (PT) and combined phacoemulsification and viscocanalostomy (PVC) in eyes with primary open-angle glaucoma (POAG).</p></div><div><h3>Methods</h3><p>In this prospective study, eighty-one consecutive patients (81 eyes) with POAG and cataract were enrolled. The eyes were randomly assigned to either the PT group (40 eyes) or the PVC group (41 eyes). The main outcomes included the success rate based on IOP and the evaluation of adverse effects during the 6-month follow-up period. The surgery was considered a complete success if the IOP was between 6 and 20 mmHg and reduced by ≥30% without glaucoma medications or additional surgery compared to the preoperative level. A qualified success was characterized by an IOP within the range of 6−20 mmHg and a 20−30% reduction in IOP achieved through the use of glaucoma medications.</p></div><div><h3>Results</h3><p>The mean baseline IOP was 23.20 ± 7.94 mmHg in the PT group and 21.29 ± 6.81 mmHg in the PVC group (<em>P</em> = 0.249). At 6 months, the mean postoperative IOP in the PT and PVC groups were 13.50 ± 2.49, and 13.73 ± 1.70, respectively. There was no significant difference in mean IOP between the groups at any time (<em>P</em> &gt; 0.05). At 6 months, 22 patients (55%) in the PT group and 22 patients (53.66%) in the PVC group achieved complete success. Nine eyes (22.50%) in the PT group and 10 eyes (24.39%) in the PVC group achieved qualified success. The other patients (9 eyes in each group) did not meet the criteria for at least a qualified success and were considered failures (<em>P</em> = 0.980). Intraoperative microperforation of Descemet's membrane occurred in 2 cases (15%) in the PVC group. Postoperative complications included 4 cases (10%) of shallow/flat anterior chamber, 1 case (2.5%) of choroidal effusion, and 1 case (2.5%) of aqueous misdirection in the PT group. The rate of these postoperative adverse effects was not significant between the two groups (<em>P</em> &gt;  0.05).</p></div><div><h3>Conclusions</h3><p>There was no significant difference in IOP reduction between PT and PVC in patients with POAG. Furthermore, PVC is safe enough in these patients, compared to PT.</p></div>","PeriodicalId":100740,"journal":{"name":"JFO Open Ophthalmology","volume":"5 ","pages":"Article 100091"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949889924000151/pdfft?md5=23aefc595ffb4b97ec39b43326d588b9&pid=1-s2.0-S2949889924000151-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140000272","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Personalised versus standardised dosing of occlusion therapy for amblyopia: A randomised controlled trial","authors":"Merrick J. Moseley ,&nbsp;Catherine E. Stewart ,&nbsp;Laura C. Bradley ,&nbsp;Alistair R. Fielder ,&nbsp;Michael P. Wallace","doi":"10.1016/j.jfop.2023.100060","DOIUrl":"10.1016/j.jfop.2023.100060","url":null,"abstract":"<div><h3>Objectives</h3><p>To compare a novel, model-based personalised dosing strategy (PDS) with a standardised (best practice) occlusion dosing strategy (SDS) for the treatment of childhood amblyopia. We have utilised archived clinical trial data sets to develop a statistical model that aims to optimise the prescription of occlusion therapy. This approach, whose effectiveness has not previously been evaluated, incorporates within its underlying model: patient age, severity and type of amblyopia.</p></div><div><h3>Methods</h3><p>Randomised, parallel group design with PDS and SDS arms each having within or pre-trial optical treatment. Actual worn occlusion for both PDS and SDS groups was objectively recorded using occlusion dose monitors (ODMs).</p></div><div><h3>Results</h3><p>Of the 94 initially enrolled participants, 50 were male, 44 female, mean [IQR] age 5.53 [4.79–6.02] years. The improvement in logMAR acuity in the 68 participants remaining in the trial subsequent to optical treatment and not having withdrawn did not differ (p = 0.641) between the PDS and SDS groups: median [IQR] improvement 0.250 [0.13−0.39] in the PDS group, 0.225 [0.14−0.32] in the SDS group. A subset (n = 28) of participants were objectively observed to have occluded for every day prescribed. In these, we found that, after allowing for slightly higher prescribed doses of occlusion in the SDS group, adherence in the PDS group to be ∼20% greater than in the SDS group.</p></div><div><h3>Conclusion</h3><p>Whilst the PDS and SDS groups demonstrated equivalent visual performance and temporal outcomes, there is evidence that the PDS results in improved adherence with therapy likely to have arisen due to increased patient engagement with this novel regimen.</p></div>","PeriodicalId":100740,"journal":{"name":"JFO Open Ophthalmology","volume":"5 ","pages":"Article 100060"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949889923000600/pdfft?md5=daf7b7d7a67b2959d7451aba050b3dee&pid=1-s2.0-S2949889923000600-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136128017","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Schnyder corneal dystrophy with late onset keratoconus development","authors":"Raman Bhakhri ,&nbsp;Jennifer Harthan ,&nbsp;Ali Djalilian","doi":"10.1016/j.jfop.2024.100093","DOIUrl":"https://doi.org/10.1016/j.jfop.2024.100093","url":null,"abstract":"","PeriodicalId":100740,"journal":{"name":"JFO Open Ophthalmology","volume":"5 ","pages":"Article 100093"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949889924000175/pdfft?md5=d551415027a4bd21c65e3fde75fd17cf&pid=1-s2.0-S2949889924000175-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140000273","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Impact of the pandemic on clinical management of glaucoma","authors":"Kshitija Mundle ,&nbsp;Brian Yu ,&nbsp;Monali S. Malvankar-Mehta","doi":"10.1016/j.jfop.2024.100080","DOIUrl":"10.1016/j.jfop.2024.100080","url":null,"abstract":"<div><h3>Objective</h3><p>To conduct a systematic review looking into the effects of the COVID-19 pandemic on the clinical management of glaucoma.</p></div><div><h3>Methods/analysis</h3><p>Literature was thoroughly searched through MEDLINE, CINAHL, Google Scholar, EMBASE, and ClinicalTrials.gov until August 5, 2020. Two levels of screening were performed independently by two authors. Kappa Statistics were used to test interrater reliability at each level of screening. The included articles were assessed for risk of bias using a checklist by CLARITY group. Data were extracted from the included articles and qualitative analysis was conducted.</p></div><div><h3>Results</h3><p>A total of 224 records were screened based on the Title/Abstract screening leaving 17 records. These 17 records went through Full-Text screening leaving 9 records for qualitative analysis. The articles outlined the barriers, recommended guidelines, and implemented guidelines used in glaucoma management during the COVID-19 pandemic. Five key pieces of information were extracted from the studies. First, the barriers to glaucoma management during the COVID-19 pandemic were extracted from all the articles. Second, pre-diagnosis and outpatient management protocols were extracted from seven of the articles. Third, specific hygiene and protective protocols that were followed during diagnosis and treatment, such as for clinical examinations, gonioscopy, tonometries, and personal protective equipment used were extracted from five of the articles. Fourth, telemedicine approaches to the management of glaucoma were extracted from four of the articles. Fifth, comprehensive information on the disinfection and sanitization protocol used in the clinical management of glaucoma was extracted from five articles.</p></div><div><h3>Conclusion</h3><p>Multiple healthcare organizations are taking sound steps in changing the clinical management of glaucoma during the COVID-19 pandemic. More studies on pre-diagnosis, outpatient management, specific hygiene, and disinfection and sanitization protocol will be helpful to ensure safer use of the equipment and effective glaucoma management in these challenging times.</p></div>","PeriodicalId":100740,"journal":{"name":"JFO Open Ophthalmology","volume":"5 ","pages":"Article 100080"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949889924000047/pdfft?md5=2af7aa4a65462068b3da325edb09d0d5&pid=1-s2.0-S2949889924000047-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139637139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Outcomes of inverted internal limiting membrane flap surgery for chronic large macular holes in a sub-Saharan African setting","authors":"Olufemi Oderinlo,&nbsp;Adekunle Hassan,&nbsp;Idris Oyekunle,&nbsp;Lateefat Oshunkoya","doi":"10.1016/j.jfop.2024.100096","DOIUrl":"https://doi.org/10.1016/j.jfop.2024.100096","url":null,"abstract":"<div><h3>Topic</h3><p>Outcomes of inverted internal limiting membrane (ILM) flap surgery for chronic large macular holes (MH) in a sub-Saharan Africa setting.</p></div><div><h3>Purpose</h3><p>To report the anatomic and visual outcomes of ILM flap surgery without face-down positioning for eyes with chronic large MH at Eye Foundation Hospital, Lagos, Nigeria.</p></div><div><h3>Design</h3><p>Retrospective, observational study.</p></div><div><h3>Methods</h3><p>Case files of patients who underwent inverted ILM flap surgery for large MH in the retina unit of the Eye Foundation Hospital, Lagos, Nigeria, between January 2022 and December 2022 were reviewed.</p></div><div><h3>Results</h3><p>The study included 30 eyes of 29 patients. MH size was between 471 μm and 1530 μm. The mean overall preoperative best corrected logMAR visual acuity was 1.27 ± 0.58. A one-line worsening of preoperative logMAR vision was associated with an increase in MH size by 129.5 μm (p = 0.056). MH closure was achieved in 90% of eyes. There was an improvement in mean best corrected postoperative logMAR visual acuity at 6 months to 0.83 ± 0.49 (p &lt; 0.001). Good visual outcomes were seen in 60.7% of eyes. The remodeling of the external limiting membrane seen in 46.7% of eyes was associated with good visual outcomes (p = 0.04).</p></div><div><h3>Conclusion</h3><p>There was a 90% anatomic closure rate for chronic large MHs that underwent inverted internal limiting membrane flap surgery among our series of patients in a sub-Saharan African setting. Good visual outcomes were seen in 60.7% of eyes, with an overall improvement in logMAR visual acuity.</p></div>","PeriodicalId":100740,"journal":{"name":"JFO Open Ophthalmology","volume":"5 ","pages":"Article 100096"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949889924000205/pdfft?md5=018a191b4c5ae80c0ff6aa1975c60503&pid=1-s2.0-S2949889924000205-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140041660","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Combination therapy versus laser monotherapy in a preterm baby with aggressive retinopathy of prematurity","authors":"Stuti Astir,&nbsp;Sandeep Kumar,&nbsp;Charu Gupta","doi":"10.1016/j.jfop.2024.100092","DOIUrl":"https://doi.org/10.1016/j.jfop.2024.100092","url":null,"abstract":"","PeriodicalId":100740,"journal":{"name":"JFO Open Ophthalmology","volume":"5 ","pages":"Article 100092"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949889924000163/pdfft?md5=0f187661ae2cddcc04101e70f001f250&pid=1-s2.0-S2949889924000163-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140041661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Determinants of retinoblastoma treatment delay in a Sub-Saharan African country","authors":"V.A Essuman ,&nbsp;B. Abaidoo ,&nbsp;K.N Amissah-Arthur ,&nbsp;V.M Beyuo ,&nbsp;A. Nimako ,&nbsp;D. Frimpong ,&nbsp;PF Ackah ,&nbsp;I.D.B Ofori-Adjei ,&nbsp;I.P Arthur ,&nbsp;G.G Kyeremeh ,&nbsp;L. Oteng-Gyimah ,&nbsp;G.B Bonsaana ,&nbsp;J. Simon ,&nbsp;B. Appiah-Thompson ,&nbsp;J.F Addy ,&nbsp;A. Ollennu ,&nbsp;L.A Renner ,&nbsp;V. Paintsil ,&nbsp;C. Guure ,&nbsp;S. Peprah ,&nbsp;H. Dimara","doi":"10.1016/j.jfop.2024.100094","DOIUrl":"10.1016/j.jfop.2024.100094","url":null,"abstract":"<div><h3>Purpose</h3><p>To examine the determinants of retinoblastoma treatment delay in children diagnosed with retinoblastoma in Ghana.</p></div><div><h3>Methods</h3><p>: The study is a retrospective cross-sectional review of hospital records of children with retinoblastoma from treatment centers in Ghana from 2014 to 2019. Data were collected by trained ophthalmology residents and nurses and entered into a REDCap (Research Electronic Data Capture) database. Frequencies and proportions were used in describing categorical variables. Independent samples t‑test and the Mann-Whitney U test were used to compare equality of means and median values. P-values less than 0.05 were considered statistically significant.</p></div><div><h3>Results</h3><p>Of the 234 children, 224 (95.7%) were referred cases and the remaining 10 (4.3%) were walk-ins. The average distance traveled by the children from home to retinoblastoma treatment center was 118.9 ± 128.4 km. The mean parental lag time was 7.6 ± 4.6 months. Longer parental lag time was associated with older age at presentation and unilateral disease (p &lt; 0.05). The mean referral lag time was 0.6 ± 0.5 months. Longer referral lag time was associated with patients who abandoned treatment or died compared with those who survived at last follow-up (p = 0.036). A total of 125 (55.8%) cases abandoned treatment after being referred and seen at a treatment center.</p></div><div><h3>Conclusion</h3><p>Analysis of the pathway from the observance of the first sign of retinoblastoma to presentation to a health facility reveals a need to reduce both parental and referral lag times in order to improve retinoblastoma outcomes. Future studies may help to unravel factors contributing to long parental lag time, referral lag time and abandonment of treatment in Ghana.</p></div>","PeriodicalId":100740,"journal":{"name":"JFO Open Ophthalmology","volume":"6 ","pages":"Article 100094"},"PeriodicalIF":0.0,"publicationDate":"2024-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949889924000187/pdfft?md5=a2ff28f5e435360e34017267c9c6667e&pid=1-s2.0-S2949889924000187-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140468714","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}